Radiomics is a rapidly growing field of radiology that extracts high-dimensional data from standard of care CT images to define a novel set of quantifiable imaging patterns – an imaging biomarker. Imaging Endpoints is a pioneer and global leader in… Read More
Imaging Endpoints has a great work environment and is leading the industry in our novel imaging technology. If you are looking for a position with great benefits and great opportunity to advance at the fastest-growing company in the imaging CRO… Read More
Imaging Endpoints’ COVID-19 analysis supports the detection and standardized recording of the clinical and radiological disease features consistent with the course of COVID-19 infection as well as the relevant epidemiological disease history. This data-driven approach offers a systematic means to… Read More
Imaging Endpoints has launched a whole new look online. Visit our new website at https://imagingendpoints.com/ and learn about all of our exciting and comprehensive novel imaging services.
Imaging Endpoints’ novel radiomic imaging technology has identified a potentially useful biomarker to non-invasively evaluate DKK1 expression according to updated clinical data presented by Leap Therapeutics Inc. The findings come from a recently completed Phase 1/2 clinical trial of DKN-01… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
